- Home
- MLTX vs SPT Comparison
MLTX vs SPT Comparison
Compare MLTX & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLTX | SPT |
|---|---|---|
| Founded | 2021 | 2010 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 863.0M | 730.1M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MLTX | SPT |
|---|---|---|
| Price | $11.50 | $11.08 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 10 |
| Target Price | ★ $28.54 | $11.11 |
| AVG Volume (30 Days) | ★ 1.8M | 811.5K |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $457,547,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $4.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 12.72 |
| 52 Week Low | $9.46 | $4.92 |
| 52 Week High | $23.29 | $13.35 |
Technical Indicators
Market Signals| Indicator | MLTX | SPT |
|---|---|---|
| Relative Strength Index (RSI) | 48.60 | 44.00 |
| Support Level | $9.73 | $10.04 |
| Resistance Level | $13.51 | $11.75 |
| Average True Range (ATR) | 0.85 | 0.70 |
| MACD | 0.08 | -0.23 |
| Stochastic Oscillator | 48.27 | 21.55 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.